The new project aims to support the inclusion in clinical trials of underrepresented groups, a move that will both help address health disparities and enhance research quality.
The new project aims to support the inclusion in clinical trials of underrepresented groups, a move that will both help address health disparities and enhance research quality.
The study was made possible thanks to EHDEN’s work on harmonising more than 350 million real-world health data records.
Thanks to WEB-RADR, a smartphone app is being used internationally for reporting side effects of medicines
IMI’s IMIDIA project set out to study the function of a certain type of cells found in the pancreas which, when malfunctioning or weak, are thought to cause diabetes. We spoke to...
IMI-supported EMBLAVEO® drug is desperately needed, says infectious disease expert
The European Medicines Agency has issued a second Letter of Support to IMI project MACUSTAR for its work on new measures to assess the eye disease age-related macular degeneration...